Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 892 participants.
Also called NCT04807400
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Phase 3
- Enrolled
- 892 participants
- Sponsor
- Registry
-
NCT04807400 -
2020-004401-31
-
- Other papers using this trial's data
- Development and application of a qualitative rapid analysis framework in a hybrid trial within primary care
- Evaluating the implementation of inclisiran in primary care: process evaluation interim findings from interviews with key stakeholders
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04807400. Randomized; no masking; primary purpose health services research. Start 2021-07-07 (actual); primary completion 2023-01-13 (actual). Results posted on 2024-03-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support
- Acronym
- SPIRIT
- Condition
- Atherosclerotic Cardiovascular Disease
- Condition
- Atherosclerotic Cardiovascular Disease Risk Equivelents
- Condition
- Elevated Low Density Lipoprotein Cholesterol
- Intervention (Drug)
- Inclisiran
- Intervention (Behavioral)
- Behavioural Support
- Intervention (Drug)
- Background lipid lowering therapy
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct04807400- Content hash
f210b64b104a092a0bea25f4d0a68dee4111dea6b5ce6510fb42b9f0626baf50